BSE filing, NSE: MKPL. Summary written from the filing by ALFA Finder's alert engine.
M K Proteins Ltd: key numbers
- Share price
- ₹3.67
- Market cap
- ₹137.8 Cr
- Revenue (annual)
- ₹382.9 Cr
- Net profit (annual)
- ₹6.83 Cr
- P/E (TTM)
- 29.3×Sector 38.3×
- Promoter holding
- 74.82%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from M K Proteins Ltd
All →M K Proteins Other Announcement
Standard quarterly shareholding pattern filing for M. K. Proteins Ltd for the quarter ended September 30, 2026.
M K Proteins Annual General Meeting
M. K. Proteins Limited conducted its 14th Annual General Meeting on September 30, 2026. Shareholders considered financial statements, director appointments, and related party transaction approvals.
M K Proteins Other Announcement
M K Proteins Limited is providing the Annual Report for FY 2025-26 to shareholders via web links and QR codes, per Regulation 36(1)(b) of SEBI LODR.
M K Proteins Annual General Meeting
M K Proteins Limited has scheduled its 14th Annual General Meeting for September 30, 2026, and approved the associated notice and directors' report.
M K Proteins Management Change
M K Proteins Limited has appointed Ms. Aritika Garg as a Non-Executive Independent Director effective August 22, 2026.
M K Proteins Board Meeting Outcome
M. K. Proteins Ltd has appointed Ms. Aritika Garg as an Additional Independent Director, subject to approval by the company's shareholders.
Other management change announcements
All →Vertex Securities Management Change
Vertex Securities appointed Ms. Unni as Independent Director and Mr. Iyer as CFO, effective October 2026. Both roles were approved at the 28 October board meeting.
Kirloskar Brothers Management Change
Kirloskar Brothers' Independent Directors Vivek Pendharkar and Rekha Sethi completed their 5-year terms on 28 Oct 2026. They ceased from the Board and all committees.
iStreet Network Management Change
iStreet Network Ltd announced the resignation of Non-Executive Non-Independent Director Mr. Yash Maheshwari effective 13 October 2026. No financial impact is indicated.
Transgene Biotek Management Change
Transgene Biotek's statutory auditors Eswara Rao & Co. resigned effective 28 October 2026 citing pre-occupation. The company will appoint new auditors per applicable regulations.
Mobavenue AI Tech Management Change
Mobavenue AI Tech appointed Vikram Sheth as Chief of Corporate Development and Investor Relations. He will lead fundraising, acquisitions and investor relations.
Hexaware Technologies Management Change
Hexaware appointed Arjun Shah and Gregory Zeluck as Non-Executive Directors from 28 October 2026. Directors Neeraj Bharadwaj and Julius Genachowski resigned, and Girish Pai's resignation is effective 13 November 2026.